EA = effect allele; OA = other allele; EAF = frequency of effect allele;
| Summary of biological annotations |
| SNP | rs11101730 |
| Chromosomal location | Chr10: 135,047,326 (10q26.3) |
| Gene (distance) | PAOX (0) |
| Predicted causal gene | unknown |
| Gene/protein classification | metabolic enzyme |
| Metabolite (Pathway) | X-03056--N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide (Polyamine metabolism; Amino acid) |
| Biochemical locus-metabolite relationship | X-03056 has been identified as N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide |
| eQTL associations | - |
| Medical information |
| Complex trait associations | - |
| Known metabolite associations | - |
| Inborn error of metabolism | - |
| Pharmacological information |
| ChEMBL ID | CHEMBL2105 |
| Drug information |
No specific drug is primarily metabolised by this enzyme; compounds with no activity in ChEMBL
|
| Locus information for top associated metabolite |
HapMap2 imputation | 1KGP imputation |